Ex-HHS official joins VaxGen board
Executive Summary
Eve Slater joins VaxGen board of directors. Slater served as assistant secretary for health and chief policy advisor to former HHS Secretary Tommy Thompson. Before joining HHS, she was Merck's VP-external policy & public affairs. Slater also serves on the board of data management solutions firm Phase Forward and Vertex Pharmaceuticals (1"The Pink Sheet" June 27, 2005, In Brief)...
You may also be interested in...
Theravance board adds Slater
Former HHS Assistant Secretary for Health Eve Slater has joined Theravance's board of directors, the firm announced Dec. 12. Before joining HHS, Slater was Merck VP-external policy & public affairs. Slater rejoins former Merck CEO and current Theravance Chairman Roy Vagelos on the board. Slater serves on the boards of a number of other firms, including Vertex and VaxGen (1"The Pink Sheet" July 18, 2005, In Brief)...
Phase Forward adds former HHS official
Eve Slater will join board of directors at Phase Forward, a provider of data management solutions for clinical trials and drug safety, on June 30. Slater was assistant secretary for health and chief policy advisor to former HHS Secretary Thompson. Before joining HHS, Slater was VP-external policy & public affairs at Merck. In addition, Covington & Burling partner and former FDA General Counsel Peter Barton Hutt is resigning his position on the Phase Forward board...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”